This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 11-14, 2026
Hynes Convention CenterBoston, MA

Content Hub

TIDES Insights: Spotlight on TIDES USA Scientific & Strategic Highlights

Explore essential topics, session highlights, and expert perspectives from TIDES USA - covering cutting-edge science, CMC strategies, delivery innovations and commercial trends shaping therapeutics in North America.

TIDES USA 2026 Keynote Spotlights

TIDES USA has long been crowned the #1 event in the industry, bringing together the brightest minds from across the global scientific community to discuss the future of oligonucleotide discovery, oligonucleotide chemistry, peptide chemistry, and peptide manufacturing. Covering the full lifecycle of macromolecular drug discovery, from early R&D through to commercialisation, the event attracts thousands of professionals each year.

But what is it about TIDES that makes it so renowned? Here’s a closer look at the 2026 keynote speakers and sessions, and why these discussions continue to shape the direction of the industry.

TIDES USA audience in session

Keynote Spotlight:

The History and Future of Oligonucleotide Manufacturing

TIDES USA speaker addressing audience

Keynote Spotlight:

Lessons Learned from a Personalized CRISPR Gene Editing Therapy

Man taking photo of a scientific poster inTIDES USA Poster Hall

Keynote Spotlight:

From Nanotechnology to Nucleic Acid Therapeutics: How Overcoming Skepticism and Barriers Led to New Cancer Treatments and Ways to Tackle a Global Health Challenge

A TIDES USA keynote presentation - full room

Keynote Spotlight:

From Sequence to Therapy: Innovations in Oligonucleotide and Genome Editing Medicines

TIDES USA Poster Hall

Keynote Spotlight:

Novel Ligands for Cell Selective Gene Silencing

A lady checking in at TIDES USA reception

Keynote Spotlight:

An Academic and Industry Perspective for Accelerating the Development of Oligonucleotide Therapeutics

Someone taking notes on their laptop in the audience of a TIDES USA keynote presentation.

Keynote Spotlight:

Precision Peptides, Powerful Impact: Protagonist Story of Peptide Innovation from Platform to Patients

TIDES USA networking hall - A woman and two men networking.

Keynote Spotlight:

Retatrutide: A Breakthrough Triagonist Uniting Molecular Design and Sustainable Manufacturing

A zoom into someone holding a diabetes injection pen

Industry Insight: GLP-1s, Peptides & the Manufacturing Challenge

An article from our editorial partner, BioXconomy.

From the rise of GLP-1 peptide therapeutics to growing pressure on manufacturing capacity and supply chains, peptide innovation is reshaping global healthcare. In partnership with BioXconomy, this news piece explores the first generic GLP-1 approval, the science behind peptide-based obesity treatments, and the urgent need for sustainable peptide manufacturing - themes that sit at the heart of discussions at TIDES USA.

News and Industry Insight

Stay up to date with BioXconomy

BioXconomy, TIDES USA's official media partner, engages the industry, builds community, and connects life sciences professionals to current, credible information, products and services relevant to their business. BioXconomy offers audiences exclusive event-based insights, updated news and features, and interactive media.